Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Bio B2BSofiva Genomics 〉Noninvasive prenatal screening by next generation sequencing of maternal plasma DNA

Noninvasive prenatal screening by next generation sequencing of maternal plasma DNA

Noninvasive prenatal screening by next generation sequencing of maternal plasma DNA

1. Non-invasive - without any concerns in preganance2. Accurate - 99.5% of sensitivity and specificity3. Fast - 8 working day report4. Early - test as early as 8 weeks gestational age5. chromosomal aneuploidies and 20 microdeletion syndromes

Request for Collaboration
Overview
Noninvasive prenatal genetic screening is an advance in the detection of fetal chromosomal aneuploidies that analyzes cell-free fetal DNA in the blood of a pregnant woman. Circulating cffDNA can be used to assess the genetic status of the fetus noninvasively. Massively parallel sequencing (MPS), allow faster and cheaper sequencing of cell-free DNA in maternal circulation. These technologies make it feasible to identify and quantify changes in the amount of fetal chromosomal DNA that signal the presence of a chromosome aneuploidy.
Application
1. who worry about the risk of invasive test
2. who are > 34-year-old
3. who find abnormalities of ultrasound screening, and having doubt of chromosomal aneuploidy
4. who had born babies with chromosomal aneuploidy
5. who are examined high risk of maternal serum screening of Down Syndrome
6. who have experienced miscarriage for several times
Collaboration Options
SOFIVA GENOMICS collaborates with the leading company of gene sequencing in the world -illumina®, which was applied in more than 500 medical centers, and introduces the patented technique, SAFeRTM, which is accumulated and tested worldwide and has the global database of 10,000,000 clinical cases, to provide the expectant mother a precise prenatal chromosomal screening with accuracy.
More Information
People who like this also like
  • FB704AFB704A
  • Scale up development & manufacturingScale up development & manufacturing
  • TAH9922 ADHD Oral SolutionTAH9922 ADHD Oral Solution
  • PipelinePipeline
  • TRIA11TRIA11
  • Chemistry Manufacturing and Controls (CMC)Chemistry Manufacturing and Controls (CMC)
  • Products PipelineProducts Pipeline
  • New combination for treating SialorrheaNew combination for treating Sialorrhea
  • OB318- New drug for anti-liver cancerOB318- New drug for anti-liver cancer
  • FuraprevirFuraprevir